North America

At the post-Iancu USPTO, will the PTAB squeeze on petitioners continue?

Changes introduced by the agency's former head have tilted the balance of power in the direction of patent owners but that trend is not guaranteed to carry on

At the post-Iancu USPTO, will the PTAB squeeze on petitioners continue?
The search for 2021’s inductees into the IP Hall of Fame is underway
1 Mar 2021

The search for 2021’s inductees into the IP Hall of Fame is underway

Nomination process now open with a new category introduced in memory of Todd Dickinson

Xperi pushes plans for patent business separation into next year
26 Feb 2021

Xperi pushes plans for patent business separation into next year

Company puts Comcast litigation firmly in rear-view mirror while announcing $635.6 million in licensing revenue for 2020

Latest

View all
25 Feb 2021

IEEE opens review of controversial patent policy

Standards body calls for “removal or revision” of factors relating to royalty calculations and injunctive relief Read more

25 Feb 2021

What life sciences businesses need to know about data commercialisation

A strategy for protecting and exploiting data is now a must for entities involved in healthcare research Read more

24 Feb 2021

Biden nominee for Attorney General pressed on the “shambles” of 101 and SEP policy

In written questions, Senator Tillis has asked Merrick Garland to back attempts to bring new patentable subject matter cases before the Supreme Court Read more

24 Feb 2021

As technology demystifies IP, money will flow into the space like never before, says Erich Spangenberg

The long read: The enfant terrible of the patent world is as hungry as ever after his move into services with IPwe. In an exclusive interview, he talks candidly about the need to dismantle silos in the ecosystem, how AI can transform patent monetisation and investment, and which country will emerge as the world’s next IP superpower Read more

Designs

View all
23 Jan 2021

Rebooting IP engagement with China need not mean giving up ground on key concerns

The patent world functions better when its two most powerful players have a constructive, though competitive, relationship Read more

4 Dec 2020

3M’s diversity pioneer on why data and collaboration are key to broadening the innovation pool

After seeing her work recognised by the IPO, the company's assistant chief IP counsel Sandra Nowak spoke with IAM on why some parts of the market are still playing catch-up Read more

21 Nov 2020

RCEP is a leap for China but a small step for IP

World’s largest trade pact is not a show-stopper when it comes to IP, but it will bring changes to ASEAN and clouds US ability to set regional agenda Read more

28 Oct 2020

Help us to identify the world's leading IP strategists

The research process for the IAM Strategy 300 2021 is now underway and we are inviting nominations as we decide who should be included Read more

Finance

View all
18 Feb 2021

Seven top IP tips for biotech SMEs

How smaller biotechs can best overcome pitfalls and maximise the value of their inventions Read more

8 Jan 2021

South Korea's Intellectual Discovery is in the process of becoming a big league, mainstream NPE

A year after a major capital infusion and a change of leadership, the firm has notched some notable settlements in the US and laid the groundwork for new assertion campaigns Read more

12 Dec 2020

It’s time for investors to re-assess intangibles

A recent report suggests Wall Street is beginning to realise that the rise of intangible assets has thrown a spanner into time-tested valuation models Read more

2 Nov 2020

Leaders of the world’s patent deals pack

The countdown of this year's IAM Market Makers - our annual ranking of the 40 most influential players in the global IP market - begins today with places 40 to 21 Read more

Frand/SEPS

View all
22 Feb 2021

US must up its game in 5G’s hidden standards battlefield to counter Chinese threat, says prominent Republican lawmaker

As America slept, claims Senator Tom Cotton, Huawei "shaped intellectual property rights standards in ways that bolstered its bottom line and strengthened its market position” Read more

20 Feb 2021

Why the US must now take the lead on SEP FRAND

Being a rule taker does not sit well with American interests nor with those of the wider global patent community. It is time for a change of approach Read more

19 Feb 2021

InterDigital reaps benefits of Huawei deal with jump in 2020 revenues; CEO Merritt eyes M&A opportunities

The patent licensor entered 2021 in a strong cash position but litigation costs ticked up thanks to Xiaomi and Lenovo fights Read more

28 Jan 2021

Failed attempt to back a single patent pool for VVC leaves operators with a choice of two

Industry vote splits between Access Advance and MPEG LA as the pair battle to sign up a new generation of innovators Read more

Law & Policy

View all
22 Feb 2021

US must up its game in 5G’s hidden standards battlefield to counter Chinese threat, says prominent Republican lawmaker

As America slept, claims Senator Tom Cotton, Huawei "shaped intellectual property rights standards in ways that bolstered its bottom line and strengthened its market position” Read more

20 Feb 2021

Why the US must now take the lead on SEP FRAND

Being a rule taker does not sit well with American interests nor with those of the wider global patent community. It is time for a change of approach Read more

16 Feb 2021

A familiar face takes key Senate IP role while USPTO director race is said to tighten

Senator Patrick Leahy was a driving force behind the America Invents Act and will play a key role in the confirmation of Andrei Iancu’s successor Read more

16 Feb 2021

The CAFC’s Amgen v Sanofi decision spells trouble for broad functional patent claims

The CAFC’s much-anticipated ruling has major implications for antibody patents and continues the court’s trend of imposing a tough enablement standard for genus claims Read more

Litigation

View all
23 Feb 2021

The changing PTAB playbook means long-neglected re-exams might be making a comeback

A rise in discretionary denials has hampered companies’ tactics when its comes to IPRs and that is prompting some to look again at an alternative USPTO proceeding Read more

18 Feb 2021

Seven top IP tips for biotech SMEs

How smaller biotechs can best overcome pitfalls and maximise the value of their inventions Read more

16 Feb 2021

The CAFC’s Amgen v Sanofi decision spells trouble for broad functional patent claims

The CAFC’s much-anticipated ruling has major implications for antibody patents and continues the court’s trend of imposing a tough enablement standard for genus claims Read more

12 Feb 2021

Ford CEO weighs in on “really embarrassing” South Korean battery trade secrets fight

With the auto giant set for a high-profile roll out of several new electric vehicles, the dispute between LG Chem and SK Innovation is once again in the spotlight Read more

Market Developments

View all
28 Jan 2021

Failed attempt to back a single patent pool for VVC leaves operators with a choice of two

Industry vote splits between Access Advance and MPEG LA as the pair battle to sign up a new generation of innovators Read more

25 Jan 2021

As Austin feels the benefits of "Texadus", the local IP market also sees a boost

With Big Tech flocking to the city and the rise of the Western District as a litigation hub, the state capital is firmly on the patent radar Read more

23 Jan 2021

Rebooting IP engagement with China need not mean giving up ground on key concerns

The patent world functions better when its two most powerful players have a constructive, though competitive, relationship Read more

19 Jan 2021

After early FRAND litigation efforts in China, KPN targets Xiaomi and others in US courts

Expanded US litigation campaign targets some of the same mobile companies Dutch firm has pursued in China for years Read more

Non-Practising Entities

View all
19 Feb 2021

InterDigital reaps benefits of Huawei deal with jump in 2020 revenues; CEO Merritt eyes M&A opportunities

The patent licensor entered 2021 in a strong cash position but litigation costs ticked up thanks to Xiaomi and Lenovo fights Read more

18 Feb 2021

Seven top IP tips for biotech SMEs

How smaller biotechs can best overcome pitfalls and maximise the value of their inventions Read more

15 Feb 2021

Open Invention Network adds major banks to membership with Barclays and TD Bank sign-ups

Risk from rivals, threats from patent assertion entities and the widespread adoption of open source software is increasing financial institutions’ interest in defensive networks, says OIN CEO Read more

10 Feb 2021

New analysis claims the economic risk posed by NPEs is set to surge

A report from RPX claims that new sources of capital make NPEs as strong as they were in the period between 2011 and 2015. Of course, they would say that - but that does not mean they are wrong Read more

Patent Pools

View all
28 Jan 2021

Failed attempt to back a single patent pool for VVC leaves operators with a choice of two

Industry vote splits between Access Advance and MPEG LA as the pair battle to sign up a new generation of innovators Read more

19 Jan 2021

VVC patents are setting the secondary market on fire

Why IP rights related to the latest video codec are this year’s must-have portfolio additions Read more

18 Jan 2021

Elite US universities come together to break technology licensing “logjam”

A group of 15 leading institutions, led by Columbia, is hoping that a new pool will unlock more value from their patents and help change the mindset of Big Tech Read more

15 Jan 2021

Oppo’s patent focus: smaller deals, younger rights and future standards

Shanghai-based R&D firm Langbo inks its first patent sale to a major Chinese buyer after a pair of deals with foreign NPEs Read more

Patents Law

View all
23 Feb 2021

The changing PTAB playbook means long-neglected re-exams might be making a comeback

A rise in discretionary denials has hampered companies’ tactics when its comes to IPRs and that is prompting some to look again at an alternative USPTO proceeding Read more

22 Feb 2021

US must up its game in 5G’s hidden standards battlefield to counter Chinese threat, says prominent Republican lawmaker

As America slept, claims Senator Tom Cotton, Huawei "shaped intellectual property rights standards in ways that bolstered its bottom line and strengthened its market position” Read more

20 Feb 2021

Why the US must now take the lead on SEP FRAND

Being a rule taker does not sit well with American interests nor with those of the wider global patent community. It is time for a change of approach Read more

19 Feb 2021

InterDigital reaps benefits of Huawei deal with jump in 2020 revenues; CEO Merritt eyes M&A opportunities

The patent licensor entered 2021 in a strong cash position but litigation costs ticked up thanks to Xiaomi and Lenovo fights Read more

Strategy

View all
11 Feb 2021

How the rise of PTAB discretionary denials impacts Hatch-Waxman strategies

The recent rejection of a Mylan IPR petition – currently being challenged at the Federal Circuit – is good news for pharma patentees and bad news for generics Read more

2 Feb 2021

The Roivant Sciences dealmaking strategy revolutionising life sciences IP monetisation

A deep dive into the trail-blazing biopharma business established by former hedge fund partner Vivek Ramaswamy Read more

26 Jan 2021

Latest move in Ericsson v Samsung shows how PTAB reforms are changing big-ticket licensing fights

The Korean tech giant has moved quickly to file a pair of IPRs against its rival’s patents but has so far not targeted any of those asserted in US district court Read more

22 Jan 2021

Chinese lidar manufacturer paid $20 million upfront plus ongoing royalties to settle Velodyne dispute

Hesai Photonics Technology reveals monetary details of settlement, which also involves ongoing royalty payments through 2030 Read more

Technology Licensing

View all
20 Feb 2021

Why the US must now take the lead on SEP FRAND

Being a rule taker does not sit well with American interests nor with those of the wider global patent community. It is time for a change of approach Read more

19 Feb 2021

InterDigital reaps benefits of Huawei deal with jump in 2020 revenues; CEO Merritt eyes M&A opportunities

The patent licensor entered 2021 in a strong cash position but litigation costs ticked up thanks to Xiaomi and Lenovo fights Read more

4 Feb 2021

Apple and Huawei patent deals continue to pay off for Qualcomm

Revenues from chip giant’s licensing business grow 18% year-on-year and division head Rogers holds out prospect of new royalty programme for auto sector Read more

2 Feb 2021

The Roivant Sciences dealmaking strategy revolutionising life sciences IP monetisation

A deep dive into the trail-blazing biopharma business established by former hedge fund partner Vivek Ramaswamy Read more

Trade Secrets

View all
18 Feb 2021

Seven top IP tips for biotech SMEs

How smaller biotechs can best overcome pitfalls and maximise the value of their inventions Read more

12 Feb 2021

Ford CEO weighs in on “really embarrassing” South Korean battery trade secrets fight

With the auto giant set for a high-profile roll out of several new electric vehicles, the dispute between LG Chem and SK Innovation is once again in the spotlight Read more

26 Jan 2021

Allergan’s Botox trade secrets win at the ITC underlines its growing importance in life sciences IP disputes

Victory for the US company and its Korean partner Medytox shows how Section 337 proceedings are becoming a vital enforcement tool for pharma and biotech rights owners Read more

7 Jan 2021

Surprise change to FDA Purple Book creates risks and opportunities for biosimilar producers

A US patent transparency amendment has mixed implications for the strategies pursued by biologics copycat producers Read more

Valuation

View all
18 Feb 2021

Seven top IP tips for biotech SMEs

How smaller biotechs can best overcome pitfalls and maximise the value of their inventions Read more

17 Feb 2021

How an army of armchair investors showed why BlackBerry is seeking buyers for its 38,000 patents

The Canadian tech giant has built a licensing operation that brings in more than $300 million annually, but those gains have failed to shift shareholder sentiment Read more

2 Feb 2021

The Roivant Sciences dealmaking strategy revolutionising life sciences IP monetisation

A deep dive into the trail-blazing biopharma business established by former hedge fund partner Vivek Ramaswamy Read more

22 Jan 2021

Chinese lidar manufacturer paid $20 million upfront plus ongoing royalties to settle Velodyne dispute

Hesai Photonics Technology reveals monetary details of settlement, which also involves ongoing royalty payments through 2030 Read more